India's Gennova Working On Omicron-Specific COVID-19 Vaccine
[email protected]24 Feb, 2022News
India's Gennova Biopharmaceuticals is working on an Omicron-specific COVID-19 vaccine candidate that could be ready in a month or two, a person with direct knowledge of the matter told Reuters. The source, who did not want to be named as the information was private, said the product might need a small trial in India before it could be rolled out as a booster or standalone vaccine. A representative for Gennova, a unit of drugmaker Emcure Pharmaceuticals that does business in some 70 countries, did not immediately respond to a request for comment.
Related Bookmarks
- Pune-Based Gennova Biopharmaceuticals Developing Vaccine For Omicron: Why This Could Be A Game Chang
- Preschool Corte Madera
- Shared Services operate with a mindset of a business and views other organizations as customers
- Valves are devices that regulate the flow of fluids by opening and closing
- Apple Unterst�tzung Berlin
- Get the Benefits For Garage Door Repair in Markham
- Antimicrobial Additives are antimicrobial agents that inhibit and prevent germs
- Peer-to-peer lending is an alternative to traditional banks
- Kia Carens Specifications
- 10 Most In-Demand Business to Open in Florida that Ordinary People Should Know in 2022
Recent Profiles
Gitartogel Online
Nhà Cái 58win
Cleo Chaya
Artixan Modulars Llp
79king
Topbet
Crossed Arrow Earthworks, Llc
Nsfwai
Gahrïelle Design Studio
Singleton Head